A major breakthrough in cancer study is occurring with the use of mini-antibodies to reactivate dysfunctional p53. This vital malignant inhibitor protein is frequently inactivated in several kinds of cancer, resulting https://wise-social.com/story7529873/vhh-fragments-reactivate-the-p53-protein-new-new-hope-for-malignant-management